Schonfeld Strategic Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-78,697	Closed	-$13M	–	2684
2021 Q2	$13M	Buy	+78,697	New	+$13.1M	0.14%	228
2020 Q1	–	Sell	-7,400	Closed	-$822K	–	1668
2019 Q4	$822K	Sell	7,400 -2,300	-24%	-$237K	0.02%	570
2019 Q3	$963K	Buy	9,700 +170	+2%	+$16.9K	0.03%	480
2019 Q2	$945K	Buy	9,530 +4,820	+102%	+$460K	0.03%	460
2019 Q1	$520K	Sell	4,710 -4,700	-50%	-$491K	0.02%	680
2018 Q4	$866K	Buy	9,410 +6,610	+236%	+$669K	0.03%	510
2018 Q3	$309K	Buy	+2,800	New	+$292K	0.01%	685

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Schonfeld Strategic Advisors's PRAH Position: Q3 2021 in Review

Schonfeld Strategic Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 78,697 shares — an estimated $13M sold.

Schonfeld Strategic Advisors first reported a position in PRAH in Q3 2018 and held it in 7 quarters. The position peaked at $13M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Schonfeld Strategic Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Schonfeld Strategic Advisors sold 78,697 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $13M.
Schonfeld Strategic Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 7 quarters.
Schonfeld Strategic Advisors's PRA Health Sciences, Inc. position peaked at $13M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.